- Entry level
- No Education
- Salary to negotiate
Pricing Implementation Lead
The Pricing Implementation Lead will drive competitive advantage and performance of AZ oncology brands by optimising price and reimbursement on a regional/global level.
You will work in close collaboration with the Global Pricing Implementation (GPI) team and the Oncology Market Access and Pricing (OMAP) team in the Oncology Business Unit (OBU) with a focus on OBU markets and oncology brand but to also critically bridge the expertise and insights developed within the OBU into the rest of AZ markets to support the optimisation of price implementation for AstraZeneca oncology brands.
Develop and maintain information and insights into the P&R environment of the countries with a particular focus on oncology (Germany, UK, France, Italy Spain, China and Japan)
Ensure an appropriate pricing policy and governance process is in place to ensure pricing strategies are implemented and monitor compliance to this
Engage with markets actively to support the optimal implementation of AZ pricing policies#
Provide forward-looking analysis into the future of price assumptions for oncology brands in OBU markets and support the LRP (2 year horizon) assumption modelling in GPI
Use this expertise to provide country specific input to Global pricing policies for new product launches-with a focus on representing a global perspectve reaching beyond the OBU markets
Lead execution of pricing strategies in collaboration with OPRDs (Oncology Pricing and Reimbursement Directors) and Regions: Establish Launch Sequence, target prices and negotiation strategies to optimize pricing and reimbursement
Pricing Center of Excellence
Liaise with Market Access & Government Affairs teams to build evidence that helps optimise pricing and market access on country and product level (e.g. provide recommendations on optimal reference baskets, cross-country implications of local cost containment measures, etc.)
Develop innovative pricing skills in the organization, pilot innovative pricing models and drive knowledge of this across markets and brands and regions
Analyze and challenge pricing assumptions of budget and long term forecasts
Influence AZ strategic decisions based on our pricing expertise in analytical and market access projects (e.g. pricing policies of AZ brands, pack rationalisation, country risk assessment)
Monitor the pricing policies for existing brands to determine if a policy refresh is required and lead the work of pricing policies review of oncology brands
Ensure AZ governance tool (PRICE) is used consistently and seek to enhance it further
Operate and seek to enhance further pricing models (Global/regional launch sequence, reference pricing)
Lead infrastructure projects aiming at sharing and improving the team technical know & how
Ensure that OBU markets are fully engaged in the use of PRICE and provide accurate and timely information and assumptions.
Extensive experience in the pharmaceutical industry in business related roles
Relevant experience in pricing and reimbursement fields in Pharmaceutical industry
Comprehensive knowledge of pricing, legal, regulatory and reimbursement issues across key markets and their impact
Ability to handle complex problem solving (involving many decision-makers and multiple, creative solutions)
Fluency in English
Clinical and/or health economics and outcomes research
Negotiating experience with payers
University degree: MD, health economics or finance
AstraZeneca is an equal opportunity employer. AstraZeneca will consider all qualified applicants for employment without discrimination on grounds of disability, sex or sexual orientation, pregnancy or maternity leave status, race or national or ethnic origin, age, religion or belief, gender identity or re-assignment, marital or civil partnership status, protected veteran status (if applicable) or any other characteristic protected by law.
Opening date: 23rd November 2018
Closing date: 21st December 2018
About the company
AstraZeneca is a global, science-led biopharmaceutical company that spans the discovery, development, manufacturing, distribution and worldwide commercialisation of primary care and speciality care medicines.
We believe the best way we can help patients is to focus on breakthrough science in order to uncover disease mechanisms and develop novel, targeted therapies that interact with them. This is at the heart of our purpose as a company: to push the boundaries of science to deliver life-changing medicines.
We invest in distinctive science in three main therapy areas where we believe we can make the most meaningful difference to patients: oncology; cardiovascular and metabolic diseases; and respiratory, inflammation and autoimmunity. Our science exploits our rare combination of capabilities in small molecules and biologics, immunotherapies, protein engineering technologies and devices. These are reinforced by a strong focus on translational science and personalised healthcare capabilities. We build on our own capabilities by collaborating with world-renowned scientists and academic institutions and partnering with like-minded science-led companies.
Through leading in science, we are confident that we can transform the lives of people around the world and deliver value to our shareholders.